{"task": "ade_corpus_v2-dosage", "input": "An 83-year-old man receiving glipizide 10 mg bid developed symptomatic hypoglycemia within three days of adding trimethoprim/sulfamethoxazole (TMP/SMX) to his regimen. [SEP] TMP", "output": "10 mg", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "Mean time between initiation of gemcitabine therapy and onset of HUS was 7.4 +/- 3.5 months, or 21.9 +/- 10.9 doses of gemcitabine. [SEP] gemcitabine", "output": "21.9 +/- 10.9", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "After initiation of topical vitamin D3 ointment (20 micro g/g of tacalcitol) 10 g/day for the skin lesions, both the serum level of calcium and urinary excretion of calcium increased gradually. [SEP] vitamin D3", "output": "20 micro g/g", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "Paraplegia following prophylactic intrathecal cytosine arabinoside (Ara-C) is described in a patient with acute myelogenous leukemia in remission who received doses of 100 mg/m2/d for 5 consecutive days. [SEP] cytosine arabinoside", "output": "100 mg/m2/d", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "The case reported here is of a child given a large dose of intravenous iron sucrose (16 mg/kg) over 3 hours, who subsequently developed features of systemic iron toxicity. [SEP] iron sucrose", "output": "16 mg/kg", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "We report five cases of carboplatin (CBDCA) hypersensitivity after weekly low-dose paclitaxel (60 mg/m2)/CBDCA (area under the concentration curve = 2) therapy in patients with recurrent ovarian cancer receiving multiple platinum-based chemotherapy. [SEP] carboplatin", "output": "60 mg/m2", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "We report a case of drug-induced Kaposi's sarcoma (KS) on the sole of the right foot in a 71-year-old man, treated for 6 months with corticosteroid therapy (prednisolone 25 mg/day) for pericardial effusion. [SEP] prednisolone", "output": "25 mg/day", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "She continued to receive regular insulin 4 times per day over the following 3 years with only occasional hives. [SEP] insulin", "output": "4 times per day", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "We report on 7 patients (2 women, 5 men) with chronic renal failure, who developed under a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day) fatal neuromyeloencephalopathy. [SEP] muzolimine", "output": "high dosage", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "We observed 2 cases of hepatotoxicity after a high-dose methylprednisolone treatment of a demyelinating disease and evaluated the potential relationship in the light of available evidence. [SEP] methylprednisolone", "output": "high-dose", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "A patient with rheumatoid arthritis developed an acute intrahepatic cholestasis after 100 mg of sodium aurothiomalate. [SEP] sodium aurothiomalate", "output": "100 mg", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "Three patients received respectively 190 mg, 175 mg, and 196 mg of methotrexate and developed bilateral pulmonary infiltrates without evidence of peripheral blood eosinophilia. [SEP] methotrexate", "output": "175 mg", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "On the fifth day after administration of a high dose of ARA-C (2 g/m2 intravenously every 12 hours), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day. [SEP] ARA-C", "output": "high", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "We describe the infectious toxicities experienced by the first two patients in our institution treated with dexamethasone (10 mg/m(2)/day for 4 weeks with gradual tapering) during induction according to the dexamethasone arm of BFM 2000 and review the relevant literature that suggests an increased risk of infectious complications with dexamethasone. [SEP] dexamethasone", "output": "10 mg/m(2)/day", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "CASE SUMMARY: An 80-year-old white female, followed up at the Memory Clinic for mild cognitive impairment, had been taking propafenone 900 mg/d for >10 years for paroxysmal atrial fibrillation without adverse effects. [SEP] propafenone", "output": "900 mg/d", "options": []}
{"task": "ade_corpus_v2-dosage", "input": "This report describes an individual with mental retardation who experienced behavioral exacerbation associated with clonazepam prescribed at 2 mg/day (0.02 mg/kg/day) to treat aggression, self-injurious behavior, property destruction, and screaming, which was measured with a 15-minute partial interval recording measurement method. [SEP] clonazepam", "output": "0.02 mg/kg/day", "options": []}
